Xcout IntelImmuCell Corporation
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.
Subscribe to see ImmuCell Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ImmuCell Corporation at a glance
ImmuCell Corporation is a biotech company headquartered in Portland, United States. It is publicly listed (ICCC) with a market capitalisation of $95.5M. Xcout tracks 19 named people at ImmuCell Corporation, including Paul F. Olivier Te Boekhorst (President, Chief Executive Officer & Director).
ImmuCell Corporation leadership
- Paul F. Olivier Te BoekhorstPresident, Chief Executive Officer & Director
- Timothy C. FioriCFO, Secretary & Treasurer
- Bobbi Jo BrockmannSenior Vice President of Sales & Marketing
- A. Gustavo ScaffaSenior Director of Quality
- Elizabeth S. ToothakerDirector of Finance & Administration and Controller
- John W. ZinckgrafDirector of Product Development
13 more named people on record for ImmuCell Corporation, with roles, board committees and tenure — see the full roster →
ImmuCell Corporation competitors
A few of ImmuCell Corporation's closest competitors — see the full list of competitors and alternatives →
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
Advanced Animal Diagnostics Inc. is headquartered in Morrisville, North Carolina, providing diagnostic technologies for the animal health sector.
Cambridge Technologies is an animal health company that provides veterinary diagnostic services and custom autogenous vaccines for bovine, swine, small ruminant, and poultry industries. Using next-generation diagnostics and specialized manufacturing, the company helps veterinarians identify pathogens and produce herd-specific vaccines to manage animal diseases.
Bionote USA is a research and development company specializing in animal health diagnostics, providing veterinary lab diagnostics equipment and point-of-care tests for pet professionals.
MI:RNA Ltd is a data-science-driven biotechnology company specializing in veterinary diagnostics. The company develops innovative companion and production animal tests utilizing microRNA biomarkers to redefine animal healthcare practices.
Get ImmuCell Corporation's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ImmuCell Corporation? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ImmuCell Corporation in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access